Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

This bill would require New Jersey Medicaid to cover ovulation-enhancing drugs and related medical services for people aged 21-44 experiencing infertility. It defines infertility as failure to conceive after 12 months of regular, unprotected sex for ages 21-34, or six months for ages 35-44. Covered services include office visits, hysterosalpingograms, pelvic ultrasounds, and blood testing. The coverage would apply only when federal funding is available for Medicaid programs. This would expand existing Medicaid benefits to include fertility treatments for this specific population.